CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
| RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
| Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
| Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
| Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
| FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
| Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
| Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
| Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
| Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |